Back
Context Therapeutics, Inc. 10K Form
Sell
50
CNTX
Context Therapeutics, Inc.
Last Price:
$1.27
Seasonality Move:
-30%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CNTX News And Ratings
See the #1 stock for the next 7 days that we like better than CNTX
CNTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.80 |
| Price / Book: | 1.59 |
Profitability
| EPS (TTM): | -0.27990 |
|---|---|
| Net Income (TTM): | $-26.4M |
| Gross Margin: | $-52.7K |
| Return on Equity: | -31.05% |
| Return on Assets: | -29.79% |
Context Therapeutics, Inc. Earnings Forecast
Key Context Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Context Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CNTX |
| Website: | contexttherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.07 |
| Quick Ratio: | 12.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CNTX Technical Analysis vs Fundamental Analysis
Sell
50
Context Therapeutics, Inc. (CNTX)
is a Sell
Is Context Therapeutics, Inc. a Buy or a Sell?
-
Context Therapeutics, Inc. stock is rated a SellThe current Context Therapeutics, Inc. [CNTX] share price is $1.27. The Score for CNTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.